Search Results - "Grandin, E."

Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis by Nunez, Jose I., Gosling, Andre F., O’Gara, Brian, Kennedy, Kevin F., Rycus, Peter, Abrams, Darryl, Brodie, Daniel, Shaefi, Shahzad, Garan, A. Reshad, Grandin, E. Wilson

“…Purpose This study aimed at analyzing the prevalence, mortality association, and risk factors for bleeding and thrombosis events (BTEs) among adults supported…”
Get full text

Mechanical Left Ventricular Unloading in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation by Grandin, E. Wilson, Nunez, Jose I., Willar, Brooks, Kennedy, Kevin, Rycus, Peter, Tonna, Joseph E., Kapur, Navin K., Shaefi, Shahzad, Garan, A. Reshad

“…Venoarterial extracorporeal membrane oxygenation (VA-ECMO) increases left ventricular (LV) afterload, potentially provoking LV distention and impairing…”
Get full text

It takes two to bleed: anticoagulation intensity and the host’s vascular susceptibility. Author’s reply by Nunez, Jose I., Grandin, E. Wilson

Get full text

Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes by Rame, J Eduardo, Pagani, Francis D, Kiernan, Michael S, Oliveira, Guilherme H, Birati, Edo Y, Atluri, Pavan, Gaffey, Ann, Grandin, E Wilson, Myers, Susan L, Collum, Craig, Kormos, Robert L, Kirklin, James K, Teuteberg, Jeffrey J

“…A revised definition of right heart failure (RHF) for the Society of Thoracic Surgeons Intermacs database of left ventricular assist devices (LVADs) was…”
Get full text

Patterns of Cardiac Toxicity Associated With Irreversible Proteasome Inhibition in the Treatment of Multiple Myeloma by Grandin, E. Wilson, MD, MPH, Ky, Bonnie, MD, MSCE, Cornell, R. Frank, MD, Carver, Joseph, MD, Lenihan, Daniel J., MD

“…Abstract Carfilzomib is a novel irreversible proteasome inhibitor (PI) used with increasing frequency to treat patients with relapsed and/or refractory…”
Get full text

Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support by Kiernan, Michael S, Grandin, E Wilson, Brinkley, Jr, Marshall, Kapur, Navin K, Pham, Duc Thinh, Ruthazer, Robin, Rame, J Eduardo, Atluri, Pavan, Birati, Edo Y, Oliveira, Guilherme H, Pagani, Francis D, Kirklin, James K, Naftel, David, Kormos, Robert L, Teuteberg, Jeffrey J, DeNofrio, David

“…To investigate preimplant risk factors associated with early right ventricular assist device (RVAD) use in patients undergoing continuous-flow left ventricular…”
Get full text

Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes by Ghajar, Alireza, Ordonez, Cesar Palacios, Philips, Binu, Pinzon, Pablo Quintero, Fleming, Lisa M., Motiwala, Shweta R., Sriwattanakomen, Roy, Ho, Jennifer E., Grandin, E. Wilson, Sabe, Marwa, Garan, Arthur Reshad

“…Observational and trial data have revealed significant improvement in cardiogenic shock (CS) mortality due to acute myocardial infarction (AMI) after…”
Get full text

Association between postoperative hemodynamic metrics of pulmonary hypertension and right ventricular dysfunction and clinical outcomes after left ventricular assist device implantation by Gulati, Gaurav, Grandin, E. Wilson, DeNofrio, David, Upshaw, Jenica N., Vest, Amanda R., Kiernan, Michael S.

“…While preoperative hemodynamic risk factors associated with early right heart failure (RHF) following left ventricular assist device (LVAD) surgery are…”
Get full text

Reply: Left Ventricular Mechanical Unloading During VA-ECMO: Not If, But Who and When? by Grandin, E. Wilson, Nunez, Jose I., Kapur, Navin K., Tonna, Joseph, Garan, A. Reshad

Get full text

Conventional versus restricted anti‐Xa‐guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation by Alkazemi, Afrah, Eche, Ifeoma Mary, Adra, May, Cabezas, Fausto, Patel, Parth, Rick, Katelyn, Grandin, E. Wilson

“…Objective The optimal intensity of anticoagulation for adult patients supported with extracorporeal membrane oxygenation (ECMO) remains uncertain. The…”
Get full text

Risk Prediction in AMI Shock: Goldilocks and the Search for “Just Right” by Pinto, Duane S., Grandin, E. Wilson

“…[Display omitted]…”
Get full text

Correction to: Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis by Nunez, Jose I., Gosling, Andre F., O’Gara, Brian, Kennedy, Kevin F., Rycus, Peter, Abrams, Darryl, Brodie, Daniel, Shaefi, Shahzad, Garan, A. Reshad, Grandin, E. Wilson

Get full text

Impact of renin-angiotensin-aldosterone system inhibition on morbidity and mortality during long-term continuous-flow left ventricular assist device support: An IMACS report by Brinkley, D. Marshall, Wang, Li, Yu, Chang, Grandin, E. Wilson, Kiernan, Michael S.

“…Inhibition of the renin angiotensin aldosterone system (RAAS) improves survival and reduces adverse cardiac events in heart failure with reduced ejection…”
Get full text

Outcomes With Single-Site Dual-Lumen Versus Multisite Cannulation for Adults With COVID-19 Respiratory Failure Receiving Venovenous Extracorporeal Membrane Oxygenation by O'Gara, Brian P, Tung, Matthew G, Kennedy, Kevin F, Espinosa-Leon, Juan P, Shaefi, Shahzad, Gluck, Jason, Raz, Yuval, Seethala, Raghu, Reich, John A, Faugno, Anthony J, Brodie, Daniel, Garan, A Reshad, Grandin, E Wilson

“…To determine whether multisite versus single-site dual-lumen (SSDL) cannulation is associated with outcomes for COVID-19 patients requiring venovenous…”
Get full text

Rethinking the Focus of Heart Failure Quality Measures by Grandin, E Wilson, Jessup, Mariell

Get full text

Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support: An ELSO Registry Analysis by Chung, Mabel, Cabezas, Fausto R, Nunez, Jose I, Kennedy, Kevin F, Rick, Katelyn, Rycus, Peter, Mehra, Mandeep R, Garan, A Reshad, Kociol, Robb D, Grandin, E Wilson

“…This study sought to determine the frequency, incidence rates over time, association with mortality, and potential risk factors for hemocompatibility-related…”
Get full text

Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22 by Grandin, E Wilson, Jarolim, Petr, Murphy, Sabina A, Ritterova, Lea, Cannon, Christopher P, Braunwald, Eugene, Morrow, David A

“…Galectin-3 is a β-galactoside-binding lectin that has been implicated in cardiac fibrosis and remodeling, is increased in models of failure-prone hearts, and…”
Get full text

Relation of Body Mass Index to Long-Term Survival after Cardiac Resynchronization Therapy by Grandin, E. Wilson, MD, MPH, Wand, Alison, MD, Zamani, Payman, MD, MTR, Rame, J. Eduardo, MD, MPhil, Verdino, Ralph J., MD

“…Abstract Obesity confers a paradoxical survival benefit among patients with heart failure (HF), but this obesity paradox has not been well established in…”
Get full text

Medicaid Expansion and Ventricular Assist Device Implantation: An Analysis of the INTERMACS Registry by Khatana, Sameed Ahmed M., Grandin, E. Wilson, Rame, J. Eduardo, Shen, Changyu, Yeh, Robert W., Groeneveld, Peter W.

Get full text

Predictors of Hemodynamic Response to Intra-Aortic Balloon Pump Therapy in Patients With Acute Decompensated Heart Failure and Cardiogenic Shock by Huang, Athena L, Fried, Justin A, Malick, Waqas, Topkara, Veli, DeFilippis, Ersilia M, Haythe, Jennifer, Farr, Maryjane, Yuzefpolskaya, Melana, Colombo, Paolo C, Takeda, Koji, Grandin, E Wilson, Kirtane, Ajay J, Pinto, Duane, Garan, A Reshad

“…There is renewed interest in intra-aortic balloon pump (IABP) use in chronic systolic heart failure (HF) patients with acute decompensation and cardiogenic…”
Get more information